Improving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation
- PMID: 32005123
- PMCID: PMC6995177
- DOI: 10.1186/s13014-020-1465-z
Improving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation
Abstract
Introduction: Colorectal cancer treatment requires a complex, multidisciplinary approach. Because of the potential variability, monitoring through clinical audits is advisable. This study assesses the effects of a quality improvement action plan in patients with locally advanced rectal cancer and treated with radiotherapy.
Methods: Comparative, multicentre study in two cohorts of 120 patients each, selected randomly from patients diagnosed with rectal cancer who had initiated radiotherapy with a curative intent. Based on the results from a baseline clinical audit in 2013, a quality improvement action plan was designed and implemented; a second audit in 2017 evaluated its impact.
Results: Standardised information was present on 77.5% of the magnetic resonance imaging (MRI) staging reports. Treatment strategies were similar in all three study centres. Of the patients whose treatment was interrupted, just 9.7% received a compensation dose. There was an increase in MRI re-staging from 32.5 to 61.5%, and a significant decrease in unreported circumferential resection margins following neoadjuvant therapy (ypCRM), from 34.5 to 5.6% (p < 0.001).
Conclusions: The comparison between two clinical audits showed improvements in neoadjuvant radiotherapy in rectal cancer patients. Some indicators reveal areas in need of additional efforts, for example to reduce the overall treatment time.
Keywords: Clinical audit; Clinical practice variability; Improvement Quality process; Radiotherapy process; Rectal Cancer.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.World J Surg Oncol. 2019 Aug 8;17(1):139. doi: 10.1186/s12957-019-1670-0. World J Surg Oncol. 2019. PMID: 31395058 Free PMC article. Clinical Trial.
-
Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.Int J Colorectal Dis. 2006 Jan;21(1):1-6. doi: 10.1007/s00384-005-0740-7. Epub 2005 Jun 10. Int J Colorectal Dis. 2006. PMID: 15947936
-
[Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].Orv Hetil. 2006 Oct 22;147(42):2011-20. Orv Hetil. 2006. PMID: 17165600 Review. Hungarian.
-
Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.Eur J Surg Oncol. 2016 Dec;42(12):1873-1880. doi: 10.1016/j.ejso.2016.08.009. Epub 2016 Aug 25. Eur J Surg Oncol. 2016. PMID: 27624916
-
[Cancer of the rectum: target volumes for preoperative radiotherapy].Cancer Radiother. 2002 Nov;6 Suppl 1:93s-99s. doi: 10.1016/s1278-3218(02)00231-7. Cancer Radiother. 2002. PMID: 12587387 Review. French.
Cited by
-
"Impact of regional data reporting and feedback on rectal cancer surgery quality metrics in the Surgical Care Outcomes Assessment Program (SCOAP)".Surg Open Sci. 2025 Mar 7;24:74-79. doi: 10.1016/j.sopen.2025.03.002. eCollection 2025 Mar. Surg Open Sci. 2025. PMID: 40160674 Free PMC article.